Answer
Palexia SR (tapentadol hydrochloride) can cause central sleep apnea and sleep-related hypoxemia, with central sleep apnea risk increasing in a dose-dependent manner.
Sources for this answer
- Palexia SR 250 mg prolonged-release tabletsGrunenthal Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked